Figure 1.
Mean (± SD) plasma concentration‐time profiles of omarigliptin (nM) in healthy men following the administration of single (A, linear scale; B, log‐linear scale) and multiple oral doses of omarigliptin (C).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.